FTRE

MKT CAP:$2B

Fortrea Holdings Inc.

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$17.91+$1.10 (+6.54%)

Jul 15, 2026

52W High $18.4052W Low $4.66

Company Details

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, ...

Leadership

Anshul Thakral

CEO & Director

Robert Parks

Chief Accounting Officer

Alejandro Martinez Galindo

Chief Information Officer

Dave Cooper

Chief Administrative Officer

Tracy H. Krumme

Senior VP of Investor Relations

Agnieszka M. Gallagher J.D.

General Counsel & Corporate Secretary

Hima B. Inguva

Head of Corporate Development

Oren J. Cohen M.D.

Chief Medical Officer

Sandy Kennedy

Chief Quality, Regulatory Affairs & Sustainability Officer

Leonard Scott Dove Ph.D.

President of Clinical Pharmacology Services

IPO Date

Jul 3, 2023

Website

www.fortrea.com

Key Metrics TTM

Revenue

$2.9B

- YoY

Net Income

$71M

EPS (Diluted)

Free Cash Flow

$190M

Revenue / Share

$31.28

Gross Margin

18.9%

Operating Margin

5.8%

Net Margin

2.5%

FCF Margin

6.7%

P/S

0.6x

P/E

23.4x

Revenue & Profitability

Operating Cash Flow

CapEx Spend

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Revenue by Geography

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee